Dashboard
Manage Tickers

ARTV


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

why-is-artiva-up-today
Why Is Artiva Up Today?
10/17/2025 19:07:44

Shares of Artiva Biotherapeutics, Inc. are rising Friday after the San Diego-based biotech company shared a milestone regulator...

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
10/17/2025 17:05:58

gold-falls-1-slb-posts-better-than-expected-q3-earnings
Gold Falls 1%; SLB Posts Better-Than-Expec...
10/17/2025 16:17:56

dow-gains-over-100-points-american-express-increases-2025-forecast
Dow Gains Over 100 Points; American Expres...
10/17/2025 13:55:00

Core News & Articles
Wedbush Maintains Outperform on Artiva Bio...
10/17/2025 12:29:35

Wedbush analyst Martin Fan maintains Artiva Biotherapeutics (NASDAQ:ARTV) with a Outperform and raises the price target fro...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
10/17/2025 12:13:10

Core News & Articles
Market-Moving News for October 17th
10/17/2025 11:27:43

CSX: 3% | CSX shares are trading higher after the company reported better-than-expected Q3 financial results. ARTV: 144% | Arti...

Core News & Articles
Needham Reiterates Buy on Artiva Biotherap...
10/17/2025 10:34:44

Needham analyst Gil Blum reiterates Artiva Biotherapeutics (NASDAQ:ARTV) with a Buy and maintains $18 price target.

why-csx-shares-are-trading-higher-by-over-4-here-are-20-stocks-moving-premarket
Why CSX Shares Are Trading Higher By Over ...
10/17/2025 09:55:54

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/16/2025 21:06:04

Core News & Articles
Artiva Biotherapeutics Receives FDA Fast T...
10/16/2025 20:08:51

SAN DIEGO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) (Artiva), a clinical-stage biotechnolog...

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
09/19/2025 17:06:19

Core News & Articles
Artiva Biotherapeutics Files For Mixed She...
08/06/2025 21:40:57

-SEC Filing

Core News & Articles
Artiva Biotherapeutics Q2 EPS $(0.87) Miss...
08/06/2025 20:57:53

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
07/23/2025 21:05:58

Core News & Articles
HC Wainwright & Co. Assumes Artiva Biother...
06/11/2025 11:03:51

HC Wainwright & Co. analyst Emily Bodnar assumes Artiva Biotherapeutics (NASDAQ:ARTV) with a Buy rating and announces Pr...

Core News & Articles
Needham Maintains Buy on Artiva Biotherape...
05/15/2025 10:07:17

Needham analyst Gil Blum maintains Artiva Biotherapeutics (NASDAQ:ARTV) with a Buy and lowers the price target from $23 to $18.

Core News & Articles
Artiva Biotherapeutics Announces Longer-Te...
05/13/2025 20:30:37

64% (9/14) complete response rate with AlloNK + rituximab in heavily pretreated patients that were naïve to prior CAR-T cell th...

Core News & Articles
Artiva Biotherapeutics Q1 EPS $(0.83) Miss...
05/08/2025 12:11:40

Artiva Biotherapeutics (NASDAQ:ARTV) reported quarterly losses of $(0.83) per share which missed the analyst consensus estimate...

Core News & Articles
Artiva Biotherapeutics to Reveal Longer-te...
04/28/2025 20:37:18

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION